Nuclear XBP1 expression in diffuse large B-cell lymphoma was correlated with poorer response to therapy and shorter overall survival in contrast to tumors with non-expressing XBP1 [72]. The gene discussed is XBP1; the disease is diffuse large B-cell lymphoma.